New Issues in Prevention and Treatment of Osteoporosis

Introduction

A growing international focus on women's health research has led to many significant advances affecting clinical practice. Understanding these advances is increasingly important to clinicians who provide healthcare services for women.

Osteoporosis frequently is a "silent" disease often showing no outward signs of its presence but nevertheless having a great impact on the health and well-being of postmenopausal women. The prevention and treatment of osteoporosis is now a major area of clinical research.

This presentation will discuss several emerging issues in skeletal health, including new data on the risks associated with osteoporosis, current and future therapies, and the evolving relationship between bone mineral density measurements and fracture risk.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Explain the impact of osteoporosis on postmenopausal health
  • Identify established therapeutic options for prevention and treatment of osteoporosis
  • Discuss emerging therapeutic options and ongoing research for prevention and treatment of osteoporosis
  • Understand evolving views on the relationship between BMD and fracture risk

Target Audience
This activity is designed to educate clinicians who treat postmenopausal women.

FELICIA COSMAN, MD

Dr. Felicia Cosman is a graduate of Cornell University and Stony Brook Medical School. She received her internal medicine training and completed her endocrinology fellowship at Columbia Presbyterian Medical Center. In 1988, she came to Helen Hayes Hospital, where she has been an osteoporosis specialist, clinical scientist, and Medical Director of the Clinical Research Center. Her research has included studying the causes of osteoporosis and how estrogen and SERMs work in clinical models as treatments for the disease. She is also studying experimental treatments for osteoporosis, including parathyroid hormone, and etiologies of stress fractures in military cadets. Dr. Cosman is the recipient of research grants from the National Institutes of Health, the Department of Defense, and the National Multiple Sclerosis Society as well as from several pharmaceutical companies. She has served as Clinical Director for Clinical Medicine at Columbia University since 1997 and also serves on the Editorial Board of Osteoporosis International.

Sponsored by the Pragmaton Office of Medical Education Supported by an educational grant from Eli Lilly and Company

Physician Accreditation Statement

The Pragmaton Office of Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Pragmaton Office of Medical Education takes responsibility for the content, quality, and scientific integrity of this CME Activity.

Physician Designation Statement Nursing Accreditation Statement Pharmacist Accreditation Statement
The Pragmaton Office of Medical Education designates this educational activity for a maximum of 1.0 hour(s) in category 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

This program has been reviewed and is acceptable for up to 1.0 Prescribed credit hour(s) by the American Academy of Family Physicians.
This program for 1.0 contact hour is sponsored by Buchanan & Associates, which is accredited as a provider of Continuing Education in Nursing by the: American Nurses Credentialing Center, Commission on Accreditation; California, and Florida Boards of Registered Nursing. To receive continuing education credit in California, use provider number CEP9473; in Florida, use 27I 1004. The Pragmaton Office of Medical Education is approved by the American Council on Pharmaceutical Education (ACPE) as a provider of continuing pharmaceutical education. This activity will provide a total of 1.00 contact hour(s) (0.1 CEUs) of continuing education credit for each audioconference in states that recognize ACPE-approved providers. To receive continuing education credit, use Universal Program Number 084-000-099-020-H04.

Physicians Click Here to Begin Activity

Nurses Click Here to Begin Activity

Pharmacists Click Here to Begin Activity

Term of Offering
CME/CE credit for this activity will be available through October 31, 2000. The original release of this material is October 31, 1999. CME/CE credit is offered upon successful completion of the Post-test. Upon successful completion of the entire program and post test, participants can print their CME/CE certificate online or contact Pragmaton Office of Medical Education to have their certificate mailed to them within 30 days.

This CME activity was planned and produced in accordance with the ACCME Essentials.

This activity has been reviewed by the Pragmaton Office of Medical Education Physisian and Pharmacist Advisory Boards, and they have determined that participants are eligible for 1 hour of credit.

Pragmaton Office of Medical Education Faculty Disclosure Policy
It is the policy of the Pragmaton Office of Medical Education that faculty members of CME/CE-accredited programs must disclose any significant financial interest, arrangement, or affiliation with a corporate organization that may have an impact on the faculty member's presentation, such as grants, research support, honoraria, member of speakers' bureau, consultant, major stock shareholder, etc. The following information is provided:

Felicia Cosman, MD
Researcher: Wyeth-Ayerst Laboratories; SmithKline Beecham Pharmaceuticals; Eli Lilly and Company. Speakers' bureau: Merck & Co., Inc.; Eli Lilly and Company. Shareholder: Merck & Co., Inc.; Oster.

Pragmaton Office of Medical Education Mission Statement

Our mission is to promote excellence in continuing professional medical education by developing and implementing activities that meet national and regional healthcare needs. In these objective and fair balanced activities, we strive to transfer new knowledge and skills into the clinical setting, improve professional practice, and enhance patient care.

Areas of expertise include women's health, cardiology, neurology, psychiatry, endocrinology, and ophthalmology. Because of the scope and content of programming, the Pragmaton Office of Medical Education develops a variety of multidisciplinary activities for primary and specialty care physicians, nurses, pharmacists, and other allied healthcare professionals. Methods of educational delivery include live presentations, self-study materials, and interactive electronic media including the use of the Internet.

In addition, the Pragmaton Office of Medical Education has established collaborative relationships with nonaccredited providers who share our mission in meeting national and regional healthcare needs.

The Pragmaton Office of Medical Education, under the guidance of both a Physician and Pharmacist Advisory Board, is supported by Pragmaton's senior management and receives support and commitment from healthcare companies.

There is no fee for this activity.

 

1999, Pragmaton. All rights reserved.

No part of this publication may be produced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical photocopying, recording, or otherwise, without the prior permission of this author

Terms of Use Privacy Statement